{
    "data": [
        {
            "id": 2992744,
            "title": "Empress Royalty Posts Record 2025 Results and Targets Higher GEO Output in 2026",
            "description": "<html><head></head><body><p></p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p><p>Empress Royalty ( <a data-ticker=\"TSE:EMPR\" href=\"https://www.tipranks.com/stocks/tse:empr\">(TSE:EMPR)</a> ) has issued an announcement.</p>\n<p></p>\n<p></p><p>Empress Royalty reported a record year in 2025, doubling revenue and delivering US$17.2 million in royalty and streaming income, US$12.1 million in gross profit, and US$7.4 million in net income, alongside positive operating cash flow of US$3.7 million and adjusted EBITDA of US$13.9 million. Management highlighted the strength and high-margin profile of its portfolio and issued 2026 guidance of 7,045 to 7,430 attributable gold equivalent ounces, signaling expectations for further growth supported by ongoing production from key assets and stable or improving gold and silver markets.</p>\n<p>The company emphasized its disciplined capital allocation and improved balance sheet, positioning it to redeploy capital into selective, value-accretive royalty and streaming opportunities. By focusing on attributable gold equivalent ounces as a core performance metric, Empress aims to demonstrate diversified exposure to gold and silver production while reducing reliance on short-term price volatility and reinforcing its competitive position among precious metals royalty players.</p>\n<p>The most recent analyst rating on <a data-ticker=\"TSE:EMPR\" href=\"https://www.tipranks.com/stocks/tse:empr\">(TSE:EMPR)</a> stock is a Hold with a C$1.00 price target. To see the full list of analyst forecasts on Empress Royalty stock, see the TSE:EMPR <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/tse:empr/forecast\" target=\"_blank\" ;=\"\" rel=\"nofollow\">Stock Forecast page</a></span>.</p>\n<p><b><u>Spark’s Take on TSE:EMPR Stock</u></b></p>\n<p>According to Spark, TipRanks’ <a data-autolink=\"true\" href=\"https://www.tipranks.com/compare-stocks/artificial-intelligence\">AI</a> Analyst, TSE:EMPR is a Neutral.</p>\n<p>The score is primarily supported by improved financial performance (strong margins, solid cash conversion, and low leverage), but tempered by concerns about consistency given the short track record of sustained profitability. Technical signals are currently soft and valuation looks relatively rich on P/E with no dividend support, while corporate updates are generally constructive.</p>\n<p>To see Spark’s full report on TSE:EMPR stock, <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/tse:empr/ai-stock-analysis\" target=\"_blank\" ;=\"\" rel=\"nofollow\">click here</a></span>. </p>\n<p><b><u>More about Empress Royalty</u></b></p>\n<p>Empress Royalty Corp. is a Vancouver-based precious metals royalty and streaming company focused on gold and silver. By investing in royalties and streams on producing and near-producing mines, it aims to provide shareholders with leveraged exposure to metal prices and high-margin cash flow without taking on direct operating risk.</p>\n<p><b>Average Trading Volume:</b> 572,098</p>\n<p><b>Technical Sentiment Signal:</b> Buy</p>\n<p><b>Current Market Cap:</b> C$158.2M</p>\n<p></p>\n<p></p><p>See more insights into EMPR stock on <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/tse:empr\" target=\"_blank\" ;=\"\" rel=\"nofollow\">TipRanks’ Stock Analysis page</a></span>.</p><p></p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_2003804756-1-750x406.jpg",
            "link": "https://www.tipranks.com/news/company-announcements/empress-royalty-posts-record-2025-results-and-targets-higher-geo-output-in-2026",
            "author": "TipRanks Canadian Auto-Generated Newsdesk",
            "pub_date": "2026-02-28 10:12:37",
            "source": "tipranks_announcements",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2992421,
            "title": "Taiga Building Products Hit by U.S. Impairment as 2025 Profit Declines",
            "description": "<html><head></head><body><p></p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p><p>The latest update is out from Avarga Limited ( <a data-ticker=\"SG:X5N\" href=\"https://www.tipranks.com/stocks/sg:x5n\">(SG:X5N)</a> ).</p>\n<p></p>\n<p></p><p>Taiga Building Products reported that fourth-quarter 2025 net sales fell 8% to $359.6 million amid lower lumber prices and reduced volumes, though gross margin dollars were stable and margin percentage improved on lower product costs. The quarter swung to a net loss of $9.1 million from a $6.6 million profit after a $20.5 million non-cash impairment of goodwill and intangibles at its Washington State subsidiary, reflecting weaker U.S. housing market conditions.</p>\n<p>For full-year 2025, net sales were essentially flat at $1.63 billion, but gross margin rose modestly to $176.4 million due to cheaper product costs despite softer pricing and volumes. Annual net earnings dropped to $28.6 million from $47.6 million and EBITDA declined to $56.7 million from $79.8 million, as the U.S. unit’s impairment weighed on profitability even as management signaled confidence in a longer-term recovery in U.S. housing and renovation markets.</p>\n<p><b><u>More about Avarga Limited</u></b></p>\n<p>Taiga Building Products Ltd. is a North American distributor of lumber and building materials, supplying a range of wood products to construction and renovation markets. The company operates across Canada and the U.S., with exposure to housing and repair-and-remodel activity, including a subsidiary in Washington State that serves regional demand.</p>\n<p><b>Average Trading Volume:</b> 6,062</p>\n<p><b>Technical Sentiment Signal:</b> Buy</p>\n<p><b>Current Market Cap:</b> S$126.1M</p>\n<p></p>\n<p></p><p>Learn more about X5N stock on <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/sg:x5n\" target=\"_blank\" ;=\"\" rel=\"nofollow\">TipRanks’ Stock Analysis page</a></span>.</p><p></p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2023/06/Industrials-2-750x406.jpg",
            "link": "https://www.tipranks.com/news/company-announcements/taiga-building-products-hit-by-u-s-impairment-as-2025-profit-declines",
            "author": "TipRanks Singapore Auto-Generated Newsdesk",
            "pub_date": "2026-02-28 09:12:14",
            "source": "tipranks_announcements",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2992293,
            "title": "Churchill Downs Earnings Call Highlights Derby-Fueled Growth",
            "description": "<html><head></head><body><p>Churchill Downs (<a data-ticker=\"CHDN\" href=\"https://www.tipranks.com/stocks/chdn\">(CHDN)</a>) has held its Q4 earnings call. Read on for the main highlights of the call. </p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p>\n<p>Churchill Downs’ latest earnings call struck an upbeat tone as management highlighted record net revenue, record adjusted EBITDA and a powerful $700 million in free cash flow for 2025. While earnings came in just shy of last year’s peak and some regional pressures surfaced, executives framed these as manageable headwinds against a strong growth and deleveraging story into 2026.</p>\n<h2>Record Revenue and Adjusted EBITDA Streak Extends</h2>\n<p>Churchill Downs reported record net revenue and record adjusted EBITDA for 2025, including record fourth-quarter figures. Excluding the pandemic year, this marks nine consecutive years of record top-line and adjusted EBITDA performance, reinforcing the company’s ability to compound growth through both its racing and gaming platforms.</p>\n<h2>Kentucky Derby and Derby Week Powerhouse</h2>\n<p>The Kentucky Derby franchise remained the crown jewel, delivering record handle for the race, Derby Day program and Derby Week overall. The company also posted the highest television ratings in nearly four decades and expects the 2026 Derby to generate an additional $15 million to $20 million of incremental adjusted EBITDA.</p>\n<h2>Robust Free Cash Flow and Shareholder Returns</h2>\n<p>Free cash flow surged to a record $700 million, or $9.75 per share, underscoring the cash-generative nature of the portfolio. Management deployed this strength by repurchasing over 4.2 million shares, returning more than $456 million to shareholders through buybacks and dividends, and extending its streak of annual dividend-per-share increases to 15 years.</p>\n<h2>HRM Footprint Expansion and New Projects</h2>\n<p>The company continued to build out its historical racing machine network with new openings in Owensboro, Marshall Yards and Roseshire, alongside progress on The Rose project. It also announced a major $180 million to $200 million investment in the Rockingham Grand Casino in Salem, New Hampshire, signaling confidence in long-term regional demand.</p>\n<h2>Wagering Services Growth Led by Exacta</h2>\n<p>The Wagering Services and Solutions segment posted a 7% increase in adjusted EBITDA for 2025, driven primarily by growth in Exacta. Management highlighted ongoing momentum in business-to-business deployments, adding new customers in Kansas and Alabama that broaden the distribution of its wagering technology.</p>\n<h2>Electronic Table Games as a New Growth Avenue</h2>\n<p>Churchill Downs secured regulatory approval in Kentucky and launched roulette electronic table games in early February, opening a new product channel. While the ETG rollout contributed nothing to 2025 results, the company views the early-stage deployment and potential additions like craps and blackjack as a meaningful long-term earnings lever.</p>\n<h2>Churchill Downs Racetrack Upgrades and Capacity Gains</h2>\n<p>At the flagship racetrack, the company completed renovations including the starting gate Pavilion for roughly 8,100 guests and a redesigned Paddock. Ongoing work on the Mansion and Finish Line Suites remains on time and on budget, and the upcoming Victory Run project will add about 1,400 seats, a 22% capacity boost in that premium area.</p>\n<h2>Disciplined Capital Allocation and Leverage Management</h2>\n<p>Maintenance capital expenditure totaled $70 million in 2025 with expectations rising to $90 million to $110 million in 2026, while project capex was $205 million and is guided to $180 million to $220 million next year. Bank covenant net leverage stood at 4.1x at year-end 2025, and management anticipates this ratio falling below 4.0x during 2026 as strong cash flow supports further balance sheet improvement.</p>\n<h2>Earnings Below Peak Amid Tough Comparisons</h2>\n<p>Despite record revenue and adjusted EBITDA, management acknowledged that overall earnings landed slightly below the prior year’s record level. The company cited challenging year-over-year comparisons and pockets of economic uncertainty earlier in 2025, but stressed that core demand trends and project execution remain on track.</p>\n<h2>Tariff Volatility and Sales-Cycle Disruptions</h2>\n<p>Executives flagged that <a data-autolink=\"true\" href=\"https://www.tipranks.com/compare-stocks/stocks-hurt-by-trump-tariffs\">tariff</a>-related volatility and broader macro uncertainty disrupted the sales process for certain events late in the selling cycle. This timing issue weighed on revenue cadence earlier in 2025, but was portrayed as a transitory factor rather than a structural change in demand.</p>\n<h2>Regional Gaming Margins Face Mild Pressure</h2>\n<p>Same-store wholly owned casino margins, excluding racing, slipped by 0.8 percentage points versus 2024, with softness concentrated in Mississippi. Management linked this modest compression to local market challenges and emphasized that the overall regional portfolio remains resilient and profitable.</p>\n<h2>Weather and Local Issues Temporarily Impact Operations</h2>\n<p>Significant January weather events and localized disruptions, including roadwork and curfews in Mississippi plus adverse conditions in December, created short-term revenue headwinds. The company noted that underlying customer demand held up well once these temporary obstacles eased.</p>\n<h2>Deliberate ETG Rollout Strategy</h2>\n<p>The ETG initiative remains in a measured ramp-up phase, starting with roulette and expanding only as products prove themselves with customers and regulators. Management stressed that ETGs provided no incremental benefit to 2025 results and are being managed as a multi-year earnings opportunity rather than a quick fix.</p>\n<h2>Regulatory and Legislative Uncertainty</h2>\n<p>The company continues to monitor legislative developments around iGaming and other competitive shifts, calling out Virginia discussions as a potential risk to its operations there. While management views iGaming as unfavorable for its Virginia properties, it framed this as an ongoing policy watch item rather than an immediate financial shock.</p>\n<h2>Guidance Signals Confident 2026 Outlook</h2>\n<p>Looking ahead, Churchill Downs expects the 2026 Kentucky Derby to contribute $15 million to $20 million of incremental adjusted EBITDA as Derby Week expands to seven live race dates across eight days with attendance around 75,000 and pacing already ahead of prior years. Project capex is projected at $180 million to $220 million, maintenance capex at $90 million to $110 million and leverage is expected to drop below 4.0x, supported by continued strong cash generation after 2025’s $700 million free cash flow.</p>\n<p>Overall, the earnings call painted the picture of a company leaning into its marquee Derby brand, expanding HRM and ETG platforms and returning significant capital while keeping leverage in check. Short-term margin and macro bumps were acknowledged but framed as manageable, leaving investors with a narrative centered on sustained cash flow, disciplined investment and a constructive growth trajectory into 2026 and beyond.</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2023/06/Consumer-Cylical-5-750x406.jpg",
            "link": "https://www.tipranks.com/news/company-announcements/churchill-downs-earnings-call-highlights-derby-fueled-growth",
            "author": "TipRanks Auto-Generated Newsdesk",
            "pub_date": "2026-02-28 08:29:51",
            "source": "tipranks_announcements",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2992275,
            "title": "Chemtrade Logistics Signals Record Year, Choppy 2026 Ahead",
            "description": "<html><head></head><body><p>Chemtrade Logistcs (($TSE:CHE.UN)) has held its Q4 earnings call. Read on for the main highlights of the call. </p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p>\n<p>Chemtrade Logistics’ latest earnings call painted a broadly upbeat picture, with 2025 marked as a record year despite some clear near‑term headwinds. Management highlighted improved reliability across key assets, strong water chemicals margins, and better reporting transparency, while also cautioning about raw material cost spikes, weaker caustic prices, and heavier 2026 maintenance outages.</p>\n<h2>Record 2025 Performance Sets a High Bar</h2>\n<p>Chemtrade reported 2025 as a record year, underlining strong execution across its portfolio and thanking employees for driving the performance. The tone suggested that, even with some market and cost volatility, the company exited the year in a stronger operational and financial position than before.</p>\n<h2>Water Chemicals Delivers Standout Margins</h2>\n<p>The specialty water chemicals (SWC) segment posted EBITDA margins of about 23% in 2025, underscoring its role as a key profit engine. Management stressed that these margins were achieved despite elevated input costs, reinforcing the resilience and pricing power of the water chemicals franchise.</p>\n<h2>Regen Acid Reliability on a Multi‑Year Uptrend</h2>\n<p>The regen acid business continued its steady year‑over‑year improvement in both performance and reliability, building on a positive multi‑year trend. Executives emphasized ongoing incremental gains, implying more stable production, fewer disruptions, and better earnings visibility from this segment.</p>\n<h2>Cairo and Tulsa Upgrades Target Quality and Growth</h2>\n<p>Chemtrade’s Cairo facility is progressing well through customer approval processes, with many samples in the field and a sales volume ramp expected in the second half of 2026. In parallel, Tulsa has received targeted upgrades leveraging Cairo learnings, aimed at higher product quality and potential qualification for more advanced customer applications.</p>\n<h2>New Segment Reporting to Sharpen Visibility</h2>\n<p>Starting with first‑quarter 2026 results, Chemtrade will report water chemicals as a standalone segment, improving transparency into revenue, EBITDA, and margins by line of business. Management framed this as a key step for investors and analysts to better model performance drivers and understand the contribution of SWC.</p>\n<h2>CapEx and LTIP Framework Clarified for Investors</h2>\n<p>The company outlined a sustaining capital spend of roughly $120 million to $130 million per year, providing a clearer baseline for long‑term modeling. Growth CapEx is expected around $35 million to $50 million annually, excluding any potential North Vancouver rezoning‑related spending, with long‑term incentive costs guided to a $22 million to $28 million range.</p>\n<h2>Sulphur Cost Spike Squeezes Margin Percentages</h2>\n<p>A sharp escalation in sulphur costs during 2025 weighed on reported SWC margin percentages, even as Chemtrade worked to protect absolute EBITDA levels. Management noted that when raw material prices spike, percentage margins naturally compress, hinting that margin optics should improve if sulphur prices normalize.</p>\n<h2>Caustic Soda Weakness Delays Price Recovery</h2>\n<p>Spot caustic soda prices started 2026 below the roughly US$450 per ton level assumed in guidance, reflecting temporary oversupply, notably from China, and softer demand. Chemtrade now expects a more meaningful price recovery only in the second half of 2026, pushing some earnings upside later in the year.</p>\n<h2>Heavier 2026 Turnarounds to Hit Q2 Results</h2>\n<p>The company flagged a heavier‑than‑usual turnaround schedule in 2026 for the SWC business, with outages aligning to customer maintenance cycles and creating lumpier production. A key turnaround at North in the second quarter is expected to weigh on Q2 results, making quarterly timing especially important for investors.</p>\n<h2>Merchant Acid Pricing Normalizing After Windfall</h2>\n<p>Merchant acid benefited in 2025 from exceptional spot opportunities triggered by competitor outages, boosting realized pricing. Management expects 2026 merchant acid prices to be modestly lower than last year, reverting toward more typical levels as supply conditions normalize.</p>\n<h2>Polytec Acquisition Causes Audit Timing Hiccup</h2>\n<p>Fourth‑quarter and full‑year figures were released on an unaudited basis because the late‑November closing of the Polytec acquisition added complexity and delayed audit completion. While framed as a one‑time timing issue, the move highlighted how M&amp;A can temporarily disrupt reporting schedules.</p>\n<h2>Variable Compensation Adds Noise to Corporate Costs</h2>\n<p>The strong unit price performance in 2025 drove long‑term incentive expenses to the high end of the guidance range, lifting corporate costs for the year. Management suggested that underlying program costs should be similar in 2026, but reminded investors that LTIP remains variable and can swing corporate overhead.</p>\n<h2>Guidance Points to Back‑Half Weighted 2026</h2>\n<p>For 2026, Chemtrade’s guidance assumes caustic soda prices around US$450 per ton over the year, though actual spot levels started weaker and are only expected to rebound in the second half. Sustaining CapEx is pegged at about $120 million to $130 million, growth CapEx at roughly $35 million to $55 million, LTIP at $22 million to $28 million, and earnings seasonality tilted toward stronger Q2–Q3, with Cairo’s sales ramp and heavier SWC turnarounds shaping the quarterly profile.</p>\n<p>Chemtrade’s earnings call blended confidence in record 2025 execution with realism about near‑term cost and pricing pressures. With key assets performing better, targeted growth projects advancing, and clearer capital and reporting frameworks, management is positioning the company for a stronger second half of 2026, even as investors prepare for a choppier first half and heavier maintenance year.</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_2135555081-1-750x406.jpg",
            "link": "https://www.tipranks.com/news/company-announcements/chemtrade-logistics-signals-record-year-choppy-2026-ahead",
            "author": "TipRanks Auto-Generated Newsdesk",
            "pub_date": "2026-02-28 08:26:27",
            "source": "tipranks_announcements",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2992241,
            "title": "Intellia Therapeutics Eyes 2026 Pivotal CRISPR Milestone",
            "description": "<html><head></head><body><p>Intellia Therapeutics Inc (<a data-ticker=\"NTLA\" href=\"https://www.tipranks.com/stocks/ntla\">(NTLA)</a>) has held its Q4 earnings call. Read on for the main highlights of the call. </p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p>\n<p>Intellia Therapeutics’ latest earnings call struck a cautiously optimistic tone, blending clinical momentum and strengthening financial discipline with serious safety and regulatory overhangs. Management leaned into the potential of lonvo-z as a first-in-class in vivo CRISPR therapy while acknowledging that the unresolved FDA hold on the key cardiomyopathy program continues to cap investor confidence.</p>\n<h2>Lonvo-z Phase 3 on Track for First Pivotal CRISPR Readout</h2>\n<p>Intellia confirmed that the HAELO Phase 3 trial of lonvo-z in hereditary angioedema is fully enrolled, with 80 patients recruited in roughly nine months. Top-line data are expected by mid-2026, and the company is targeting a BLA filing in the second half of 2026, positioning lonvo-z for the first pivotal readout of an in vivo CRISPR gene-editing therapy.</p>\n<h2>Robust Patient and Physician Appetite for Gene Editing in HAE</h2>\n<p>Survey work suggests a receptive U.S. market for lonvo-z if the data hold up, with 99% of patients indicating at least some willingness to take a gene-editing therapy and nearly two-thirds reporting they are extremely or very likely to do so. Among 151 U.S. physicians managing more than 4,000 patients, 92% said they could identify candidates and estimated they would prescribe lonvo-z to roughly 2,200, or about 54% of their treated population.</p>\n<h2>Durable Efficacy Signals Support Lonvo-z’s One-Time Treatment Thesis</h2>\n<p>Management highlighted durability data from early-phase studies, noting up to three years of follow-up without evidence of waning serum kallikrein or TTR suppression. A pooled analysis showed that 76% of patients at least one year beyond a 50 mg dose were free of attacks and off ongoing therapy for 12 months or more, a stark contrast with current prophylactics, where roughly 20% of patients remain attack-free.</p>\n<h2>Q4 2025 Numbers Show Improving P&amp;L Discipline</h2>\n<p>On the financial front, Intellia delivered stronger fourth-quarter metrics, with collaboration revenue rising to $23.0 million from $12.9 million, a gain of about 78% year over year. R&amp;D spending fell to $88.7 million from $116.9 million, helping narrow the quarterly net loss to $95.8 million from $128.9 million, a sign of tightening cost control as key trials mature.</p>\n<h2>Cash Runway Extends into 2027 but Headroom Has Shrunk</h2>\n<p>The company closed 2025 with $605.1 million in cash, cash equivalents and marketable securities, down from $861.7 million a year earlier, a roughly 30% decline. Management believes this balance is sufficient to fund operations into the second half of 2027 and carry Intellia through major lonvo-z milestones, while commercial manufacturing, field teams and payer outreach for a possible launch are already largely in place.</p>\n<h2>MAGNITUDE-2 ATTR Polyneuropathy Program Back in Motion</h2>\n<p>Regulatory fortunes were mixed, with the FDA lifting the clinical hold on MAGNITUDE-2 for ATTR polyneuropathy in late January after agreeing on tighter safety measures. The study now includes additional early post-dose liver testing, a short-course steroid protocol for liver function spikes and refined screening, and its enrollment target has risen to about 60 patients, with 47 already recruited heading into an expected completion in the second half of 2026.</p>\n<h2>Cardiomyopathy Trial Remains Frozen Under FDA Scrutiny</h2>\n<p>By contrast, MAGNITUDE in ATTR cardiomyopathy remains on full clinical hold after serious liver enzyme and bilirubin elevations in one patient, halting a trial that had already enrolled more than 650 participants, above its original 550-patient plan. Intellia is in ongoing dialogue with regulators and has proposed similar risk-mitigation steps, but no green light has yet been granted, leaving the largest commercial opportunity in limbo.</p>\n<h2>Serious Adverse Event Clouds Safety Profile and Adds Risk</h2>\n<p>The safety narrative was dominated by a patient in MAGNITUDE who developed Grade 4 elevations in liver transaminases and bilirubin and later died from a ruptured duodenal ulcer, with causality to treatment unclear. While the company said such severe liver events occurred in less than 1% of patients and appear immune-mediated, the mechanism is not fully understood, introducing meaningful regulatory and pipeline risk.</p>\n<h2>Cash Burn and Operational Disruption Highlight Execution Challenges</h2>\n<p>The roughly 30% year-over-year drop in cash underscores the cost of building a first-wave CRISPR business despite the improved quarterly loss profile. Operationally, the October enrollment suspension in MAGNITUDE and MAGNITUDE-2, subsequent FDA pauses and protocol amendments have added complexity and time, even as MAGNITUDE-2 now resumes under tighter monitoring requirements.</p>\n<h2>Pipeline Read-Through and HAE Reproducibility Remain Open Questions</h2>\n<p>Management acknowledged that it cannot yet definitively determine whether the liver toxicity signal is unique to the TTR target or could emerge in other in vivo CRISPR programs, leaving investors with unanswered questions about broader platform risk. Executives also flagged that Phase 1/2 HAE data came largely from ex-U.S. patients while Phase 3 includes U.S. subjects with potentially different baseline characteristics, creating some risk around how well early efficacy will translate.</p>\n<h2>Forward-Looking Outlook: Pivotal 2026 Data and Launch Ambitions</h2>\n<p>Looking ahead, Intellia framed 2026 as a pivotal year, with HAELO Phase 3 top-line lonvo-z data expected by mid-year, a planned BLA submission in the second half and a potential 2027 commercial launch if results and regulators cooperate. The company aims to complete MAGNITUDE-2 enrollment in the second half of 2026 under new liver-monitoring and steroid protocols, while managing a cash runway into late 2027 and betting that strong patient and physician interest will translate into substantial uptake if lonvo-z reaches the market.</p>\n<p>Intellia’s call painted the picture of a high-upside but high-risk story, with lonvo-z nearing a watershed CRISPR readout that could redefine HAE treatment and the company’s valuation. Yet the unresolved cardiomyopathy hold, safety uncertainties and a shrinking cash cushion temper the bull case, leaving investors to weigh breakthrough potential against regulatory and execution hazards over the next 18 to 24 months.</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_1931544818-750x406.jpg",
            "link": "https://www.tipranks.com/news/company-announcements/intellia-therapeutics-eyes-2026-pivotal-crispr-milestone",
            "author": "TipRanks Auto-Generated Newsdesk",
            "pub_date": "2026-02-28 08:20:57",
            "source": "tipranks_announcements",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2992229,
            "title": "Jamieson Wellness Earnings Call Signals Growth Momentum",
            "description": "<html><head></head><body><p>Jamieson Wellness (<a data-ticker=\"TSE:JWEL\" href=\"https://www.tipranks.com/stocks/tse:jwel\">(TSE:JWEL)</a>) has held its Q4 earnings call. Read on for the main highlights of the call. </p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p>\n<p>Jamieson Wellness’ latest earnings call struck an upbeat tone, as management leaned on double-digit top-line growth, expanding margins and a standout performance in China to frame a story of durable momentum. While higher SG&amp;A, a drop in strategic partner revenue and a working-capital build weighed on reported results, executives argued that these investments are deliberate and manageable against strong underlying profitability.</p>\n<h2>Strong Consolidated and Branded Revenue Growth</h2>\n<p>Jamieson posted about 12% full-year consolidated revenue growth, with its core branded business advancing nearly 16%, underscoring the strength of its portfolio. In Q4, consolidated revenue rose 13.4% to $277.7 million, powered by Jamieson Brands’ 17.1% gain to $237.4 million and a 20.2% jump at Youtheory.</p>\n<h2>Geographic Diversification with China and International Outperformance</h2>\n<p>China remained the star, with full-year growth above 56% and Q4 up 43.9%, making the market a key growth engine. International revenue climbed 24% for the year and 39.2% in Q4, while Canada outpaced its home market with roughly 6% full-year growth and 5.5% growth in the quarter.</p>\n<h2>Gross Profit and Margin Expansion</h2>\n<p>Consolidated gross profit increased by $18.5 million in Q4 to $118.7 million, lifting consolidated gross margin by about 180 basis points and highlighting operating leverage. Jamieson Brands’ gross profit rose 19.7%, and normalized gross margin improved 90 basis points to 47.6%, helped by a richer branded mix and scale benefits in China.</p>\n<h2>Improved Profitability and Strong Adjusted Metrics</h2>\n<p>Adjusted profitability remained a bright spot, with Q4 adjusted EBITDA up 13.7% to an unchanged margin of 24.3%, showing that growth is not diluting earnings quality. Normalized earnings from operations rose 13.3% to $60.4 million, adjusted net earnings reached $38.5 million and adjusted diluted EPS came in at $0.90.</p>\n<h2>High-ROI China Execution and Consumer Conversion</h2>\n<p>Management highlighted China as a high-return investment story, citing performance marketing that is translating awareness into sales. Brand awareness to trial conversion jumped 57%, and trial to regular-buyer conversion climbed 81%, allowing Jamieson to grow roughly four times faster than the broader vitamins, minerals and supplements market.</p>\n<h2>Strong Cash Position and Shareholder Returns</h2>\n<p>The company ended the year with $126.6 million in cash and available facilities, giving it ample flexibility despite near-term working-capital pressures. Jamieson returned capital aggressively, repurchasing about 1.2 million shares for $37.9 million and paying roughly $37.2 million in dividends, with a further $0.23-per-share dividend declared.</p>\n<h2>Operational Improvements and Innovation Momentum</h2>\n<p>Operationally, Jamieson completed the rollout of a new SAP system across headquarters and three manufacturing sites, a key step for scaling efficiently. Innovation continued to focus on high-demand need states like immunity, sleep, stress and energy, with a “global-to-local” model speeding successful products into new markets and retailers.</p>\n<h2>Strategic Partners Revenue Decline</h2>\n<p>Strategic Partner revenues were a weak spot, declining 4.4% in Q4, or about $1.9 million, as volumes softened and customer onboarding was delayed amid trade and <a data-autolink=\"true\" href=\"https://www.tipranks.com/compare-stocks/stocks-hurt-by-trump-tariffs\">tariff</a> uncertainty. Segment gross profit fell 2.4%, underscoring some sensitivity to external policy and logistics factors.</p>\n<h2>Higher SG&amp;A and One-Time Due Diligence Costs</h2>\n<p>SG&amp;A jumped 20% in Q4, or $9.8 million, as Jamieson leaned into performance marketing, especially in China, and built out global infrastructure and variable compensation. The quarter also absorbed $2.7 million of legal and professional expenses linked to due diligence on an acquisition that ultimately failed to meet return thresholds.</p>\n<h2>Reported Operating Income Nearly Flat After Investments</h2>\n<p>Despite strong growth in revenue and gross profit, reported earnings from operations were essentially flat in Q4, slipping about 0.02% as spending ramped up. Management emphasized that on a normalized basis operating income still climbed, framing the gap as largely tied to deliberate brand-building and one-off deal costs.</p>\n<h2>Working Capital Build and Cash from Operations Pressure</h2>\n<p>Cash from operations fell to $31.9 million from $37.8 million a year earlier, but performance before working capital actually improved, reflecting underlying earnings strength. The drag came from an $18.8 million working-capital increase driven by higher inventory to cushion tariff risks and port congestion, a trend management expects to continue into 2026.</p>\n<h2>M&amp;A Pipeline Caution and Deal Costs</h2>\n<p>Management signaled a cautious approach to acquisitions, noting that a recent potential deal was dropped after not meeting internal criteria even after due diligence spending. The pipeline remains focused on scaled, U.S.-based brands around $100 million or more in revenue, but timing and certainty of transactions remain unclear.</p>\n<h2>Early-Stage GLP-1-Related Opportunity and Category Sensitivities</h2>\n<p>Executives flagged GLP-1 companion products as an emerging but still modest category, with early uptake encouraging yet not material to overall results. They also cited seasonal swings, including a December immunity spike, while framing GLP-1 as a possible longer-term tailwind whose impact and timing are still difficult to forecast.</p>\n<h2>Forward-Looking Guidance and Growth Outlook</h2>\n<p>For 2026, Jamieson guided consolidated revenue to $895 million–$935 million, implying 9%–14% growth, with Jamieson Brands expected to grow 9%–13% and China projected to surge another 20%–30%. Adjusted EBITDA is forecast at $174 million–$181 million and adjusted EPS at $2.08–$2.21, alongside solid cash generation before working capital and planned investments in inventory and roughly $20 million of capex.</p>\n<p>Overall, Jamieson Wellness’ call painted a picture of a growth company investing heavily but selectively in its brands, capabilities and balance sheet resilience. For investors, the message was that strong international and China-driven expansion, rising margins and disciplined capital returns outweigh near-term noise in partner revenue, working capital and deal-related costs.</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2023/06/Consumer-Defensive-7-750x406.jpg",
            "link": "https://www.tipranks.com/news/company-announcements/jamieson-wellness-earnings-call-signals-growth-momentum",
            "author": "TipRanks Auto-Generated Newsdesk",
            "pub_date": "2026-02-28 08:15:38",
            "source": "tipranks_announcements",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2991972,
            "title": "Northern Oil and Gas Earnings Call Balances Upside and Risk",
            "description": "<html><head></head><body><p>Northern Oil And Gas (<a data-ticker=\"NOG\" href=\"https://www.tipranks.com/stocks/nog\">(NOG)</a>) has held its Q4 earnings call. Read on for the main highlights of the call. </p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p>\n<p>Northern Oil and Gas’ latest earnings call painted a mixed but ultimately constructive picture for investors. Management highlighted strong cash generation, growing production and a fortified balance sheet, even as GAAP results were hit by large non‑cash impairments and weaker commodity realizations. The tone was confident about dividend durability and upside leverage to a future recovery, while candid on near‑term volatility and activity uncertainty.</p>\n<h2>Robust Adjusted EBITDA and Free Cash Flow</h2>\n<p>Northern Oil and Gas reported adjusted EBITDA of $1.63 billion for 2025, with Q4 contributing $367 million, underscoring resilient profitability in a softer price environment. Full‑year free cash flow reached $424 million and Q4 generated $43 million, showing that the business continues to throw off meaningful cash even as commodity headwinds weigh on realized pricing.</p>\n<h2>Production Growth and Record Gas Volumes</h2>\n<p>Average daily production in Q4 climbed to 140,000 BOE per day, up 7% sequentially and 6% year over year, while full‑year volumes averaged 135,000 BOE per day, a 9% increase versus 2024. The Appalachian JV was a standout, with gas volumes hitting a third straight quarterly record at 392 MMcf per day, up 11% from Q3 and 24% from the prior year.</p>\n<h2>Ground Game Delivers Acreage Expansion</h2>\n<p>The company leaned on its non‑operated “ground game” to expand its footprint, adding more than 12,000 net acres in 2025 and ending the year with roughly 12,300 plus acres and 12.8 net wells. Q4 was a record quarter, with over 6,000 net acres and 1.2 net wells acquired across 33 deals, drawn from more than 700 evaluated opportunities, highlighting a highly selective but active acquisition engine.</p>\n<h2>Strategic Utica Deal Scales Appalachia</h2>\n<p>A centerpiece of the year was the integrated Utica acquisition alongside Infinity, anchored by assets operated by Antero. The transaction boosts Northern’s Appalachian footprint by about 45% on a pro forma basis to roughly 90,000 net acres and adds more than 100 identified gross locations, providing meaningful inventory depth and optionality across both upstream and midstream.</p>\n<h2>Liquidity Bolstered and Debt Ladder Extended</h2>\n<p>Management moved aggressively on the balance sheet, extending the revolving credit facility maturity from June 2027 to November 2030 while lifting the borrowing base to $1.975 billion and elected commitments to $1.8 billion. The company also issued $725 million of notes at 7.875%, retiring most of its 2028 notes and ending the year with more than $1 billion of liquidity following the Utica close.</p>\n<h2>Cost Efficiencies and Operational Improvements</h2>\n<p>Operationally, Northern continues to benefit from longer laterals and lower well costs, with normalized lateral lengths around 13,000 feet and normalized well costs down nearly 5% quarter over quarter. Lease operating expense improved in Q4 to $9.30 per BOE, a 5% reduction versus Q3 and 3% lower than Q4 2024, reflecting efficiency gains despite a challenging cost environment.</p>\n<h2>Disciplined Capital Allocation Across Basins</h2>\n<p>For 2025, total capital spending excluding non‑budgeted acquisitions came in at $1.0 billion, including $174 million devoted to the ground game. In Q4, CapEx excluding non‑budgeted deals totaled $270 million, with about 44% directed to the Permian, 26% to the Williston, 8% to the Uinta and 22% to Appalachia, and roughly $193 million going to organic development projects.</p>\n<h2>Dividend Resilience and Hedging Support</h2>\n<p>Management underscored that the dividend is designed to be sustainable even in a significantly weaker commodity backdrop, pointing to modest EBITDA growth despite lower prices. Adjusted EBITDA rose about 1% year over year even as average oil prices fell around 14% in 2025, a performance credited largely to effective hedging and disciplined capital allocation.</p>\n<h2>Non‑Cash Impairments Cloud GAAP Results</h2>\n<p>On the downside, reported GAAP earnings were heavily impacted by $703 million of non‑cash impairments recorded over 2025, including $270 million in Q4 alone. These write‑downs were tied to the full‑cost ceiling test and lower average oil prices, underlining how accounting rules can obscure underlying cash performance even when operations remain solid.</p>\n<h2>Weaker Realizations and Wider Differentials</h2>\n<p>Commodity realizations deteriorated, with oil differentials widening to $5.05 per barrel in Q4 from $3.89 in Q3 and averaging $5.53 for the year. Natural gas pricing was particularly pressured as realizations fell to 58% of benchmark in Q4 and averaged 79% for the year, down from 93% in 2024, driven by Waha weakness, softer NGL prices and unfavorable regional dynamics.</p>\n<h2>Oil Volumes Slip and Activity Visibility Declines</h2>\n<p>While total production grew, Q4 oil volumes of 75,000 barrels per day were up 3% sequentially but down 5% versus the prior year, reflecting mix and timing effects. Management flagged high uncertainty for 2026, citing deferred completions, operator curtailments and 13 net wells elected but not yet spud, which together introduce a wide range of possible activity outcomes.</p>\n<h2>Higher Maintenance Burden Lifts LOE</h2>\n<p>Despite efficiency gains late in the year, full‑year lease operating expense rose modestly to $9.61 per BOE, up 2% from 2024. The company attributed the increase to higher workover and maintenance costs associated with supporting growing volumes, highlighting that sustaining production across a broader asset base carries an incremental cost burden.</p>\n<h2>Share Price Pressure and Multiple Compression</h2>\n<p>Management acknowledged that shareholders did not fully benefit from the operational progress, as total equity returns were negative in 2025. The stock has suffered from multiple compression amid declining oil prices and broader market skepticism toward the sector, even as Northern improved its asset base, scale and cash generation capability.</p>\n<h2>Wide‑Range 2026 Guidance Signals Flexibility</h2>\n<p>For 2026, Northern issued a two‑case framework with low‑ and high‑activity scenarios covering production, operating costs and capital spending and assuming roughly 70 to 90 net wells. The program is anchored by about 45.6 net wells in process and 13 net wells elected but not yet spud, with a basin mix of around 40% Permian, 25% Appalachia, 25% Williston and 10% Uinta and well costs trending lower with 13,000‑foot laterals.</p>\n<h2>Forward‑Looking Outlook and Capital Optionality</h2>\n<p>Guidance suggests spending will be front‑loaded, with roughly 60% of CapEx in the first half while well activity remains roughly even, and Q1 typically slower before a Q2 ramp. In the low‑activity case, Northern expects lower oil volumes but materially reduced spending and significantly higher free cash flow at current strip, while the high‑activity case assumes fewer curtailments, more turn‑in‑lines and roughly a $100 to $150 million spending delta, with strong sensitivity to oil prices and ample liquidity to pursue either path.</p>\n<p>Northern Oil and Gas exits the year as a larger, more diversified and better‑funded non‑operator, yet one still exposed to commodity swings and operator timing. Investors are being asked to look past non‑cash impairments and near‑term pricing headwinds toward a flexible 2026 plan backed by strong liquidity, visible inventory and a dividend policy built to endure the downcycle and capture upside when conditions improve.</p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2023/06/Energy-10-750x406.jpg",
            "link": "https://www.tipranks.com/news/company-announcements/northern-oil-and-gas-earnings-call-balances-upside-and-risk",
            "author": "TipRanks Auto-Generated Newsdesk",
            "pub_date": "2026-02-28 08:06:29",
            "source": "tipranks_announcements",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2991885,
            "title": "Torrent Gold Launches $480,000 Private Placement to Strengthen Working Capital",
            "description": "<html><head></head><body><p></p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p><p>Raindrop Ventures ( <a data-ticker=\"TSE:TGLD\" href=\"https://www.tipranks.com/stocks/tse:tgld\">(TSE:TGLD)</a> ) has provided an announcement.</p>\n<p></p>\n<p></p><p>Torrent Gold Inc. plans to raise up to $480,000 through a non-brokered private placement of up to 2,400,000 common shares at $0.20 per share, with the option to increase the size of the offering subject to Canadian Securities Exchange approval. The securities issued will be subject to a four-month-plus-one-day hold period under Canadian securities laws and will not be offered in the United States.</p>\n<p>Net proceeds from the financing are expected to be directed primarily toward settling current accounts payable and strengthening general working capital, which should bolster Torrent Gold’s balance sheet and liquidity position. The move underscores the company’s ongoing effort to fund its operations and exploration strategy in a challenging junior resource financing environment while maintaining compliance with applicable securities regulations.</p>\n<p>The most recent analyst rating on <a data-ticker=\"TSE:TGLD\" href=\"https://www.tipranks.com/stocks/tse:tgld\">(TSE:TGLD)</a> stock is a Sell with a C$0.60 price target. To see the full list of analyst forecasts on Raindrop Ventures stock, see the TSE:TGLD <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/tse:tgld/forecast\" target=\"_blank\" ;=\"\" rel=\"nofollow\">Stock Forecast page</a></span>.</p>\n<p><b><u>Spark’s Take on TSE:TGLD Stock</u></b></p>\n<p>According to Spark, TipRanks’ <a data-autolink=\"true\" href=\"https://www.tipranks.com/compare-stocks/artificial-intelligence\">AI</a> Analyst, TSE:TGLD is a Neutral.</p>\n<p>The score is held down primarily by weak financial performance (no revenue, ongoing losses, negative cash flow, and shrinking equity). Technicals provide partial support due to strong momentum and price above major moving averages, but valuation remains pressured given continued losses and a negative P/E.</p>\n<p>To see Spark’s full report on TSE:TGLD stock, <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/tse:tgld/ai-stock-analysis\" target=\"_blank\" ;=\"\" rel=\"nofollow\">click here</a></span>. </p>\n<p><b><u>More about Raindrop Ventures</u></b></p>\n<p>Torrent Gold Inc. is a Vancouver-based mineral and natural resources exploration company that leverages extensive capital markets and mining experience to pursue acquisition and exploration opportunities across resource commodity cycles. The company focuses on advancing projects by timing investments and activities to align with shifts in commodity markets and investor appetite for resource assets.</p>\n<p><b>Average Trading Volume:</b> 3,004</p>\n<p><b>Technical Sentiment Signal:</b> Buy</p>\n<p><b>Current Market Cap:</b> C$1.69M</p>\n<p></p>\n<p></p><p>For an in-depth examination of TGLD stock, go to <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/tse:tgld\" target=\"_blank\" ;=\"\" rel=\"nofollow\">TipRanks’ Overview page</a></span>.</p><p></p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_1496515682-1-750x406.jpg",
            "link": "https://www.tipranks.com/news/company-announcements/torrent-gold-launches-480000-private-placement-to-strengthen-working-capital",
            "author": "TipRanks Canadian Auto-Generated Newsdesk",
            "pub_date": "2026-02-28 07:43:03",
            "source": "tipranks_announcements",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2991868,
            "title": "Redwood AI Retires Over $400,000 in Debt Through Share Issuance",
            "description": "<html><head></head><body><p></p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p><p>Redwood <a data-autolink=\"true\" href=\"https://www.tipranks.com/compare-stocks/artificial-intelligence\">AI</a> Corp. ( <a data-ticker=\"TSE:AIRX\" href=\"https://www.tipranks.com/stocks/tse:airx\">(TSE:AIRX)</a> ) has provided an update.</p>\n<p></p>\n<p></p><p>Redwood AI Corp. has completed previously announced debt settlements with a director and certain creditors by issuing 236,003 common shares at a deemed price of $1.71 per share, extinguishing $403,571.96 in outstanding indebtedness. The shares, which include issuances to entities controlled by director Kristian Thorlund and constitute related-party transactions under Canadian securities rules, are subject to a four-month-plus-one-day hold period, with the company relying on regulatory exemptions to expedite balance sheet cleanup and improve its financial position without immediate cash outlay.</p>\n<p>The related-party component of the settlement fell below 25% of Redwood AI’s market capitalization, allowing the company to avoid a formal valuation and minority shareholder approval process. Management also chose not to file an early material change report because the terms were finalized shortly before closing, underscoring a focus on swiftly reducing liabilities and potentially positioning the AI-driven drug development software provider for greater financial flexibility and strategic execution.</p>\n<p><b><u>More about Redwood AI Corp.</u></b></p>\n<p>Redwood AI Corp. is a Vancouver-based <a data-autolink=\"true\" href=\"https://www.tipranks.com/compare-stocks/artificial-intelligence\">artificial intelligence</a> company providing software and analytics solutions for chemical and pharmaceutical development. Its platform combines advanced AI models, cheminformatics, and operational data to support synthesis planning, process optimization, and supply-chain decision-making from early development through commercialization.</p>\n<p><b>Average Trading Volume:</b> 34,375</p>\n<p></p>\n<p></p><p>Find detailed analytics on AIRX stock on <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/tse:airx\" target=\"_blank\" ;=\"\" rel=\"nofollow\">TipRanks’ Stock Analysis page</a></span>.</p><p></p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_1820093804-750x406.jpg",
            "link": "https://www.tipranks.com/news/company-announcements/redwood-ai-retires-over-400000-in-debt-through-share-issuance",
            "author": "TipRanks Canadian Auto-Generated Newsdesk",
            "pub_date": "2026-02-28 07:19:02",
            "source": "tipranks_announcements",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2991863,
            "title": "Gold Runner Exploration Grants 2.5 Million Stock Options to Align Team with Growth Plans",
            "description": "<html><head></head><body><p></p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p><p>Crestview Exploration ( <a data-ticker=\"TSE:GRUN\" href=\"https://www.tipranks.com/stocks/tse:grun\">(TSE:GRUN)</a> ) has provided an update.</p>\n<p></p>\n<p></p><p>Gold Runner Exploration Inc., a gold and silver exploration company with assets in British Columbia’s Golden Triangle and multiple projects in Nevada’s major mining belts, continues to build its presence in key North American precious metals districts. The company’s portfolio spans early-stage to more advanced exploration assets, including both direct holdings and a carried interest structure that provides exposure to potential upside with limited capital commitments.</p>\n<p>Gold Runner announced the grant of 2,500,000 stock options at an exercise price of $1.22 per share to directors, officers, employees and consultants, with the options vesting immediately and expiring in five years, subject to Canadian Securities Exchange approval. The move strengthens equity-based incentives across its leadership and technical teams, aligning compensation with shareholder value creation as the company advances its exploration projects in Canada and the U.S.\n</p>\n<p>The most recent analyst rating on <a data-ticker=\"TSE:GRUN\" href=\"https://www.tipranks.com/stocks/tse:grun\">(TSE:GRUN)</a> stock is a Hold with a C$0.72 price target. To see the full list of analyst forecasts on Crestview Exploration stock, see the TSE:GRUN <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/tse:grun/forecast\" target=\"_blank\" ;=\"\" rel=\"nofollow\">Stock Forecast page</a></span>.</p>\n<p><b><u>Spark’s Take on TSE:GRUN Stock</u></b></p>\n<p>According to Spark, TipRanks’ <a data-autolink=\"true\" href=\"https://www.tipranks.com/compare-stocks/artificial-intelligence\">AI</a> Analyst, TSE:GRUN is a Neutral.</p>\n<p>The score is primarily held back by weak financial performance (no revenue, ongoing losses, and negative cash flow with reliance on financing), partially offset by strong technical momentum with the stock trading above key moving averages. Valuation remains constrained by negative earnings and no dividend support.</p>\n<p>To see Spark’s full report on TSE:GRUN stock, <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/tse:grun/ai-stock-analysis\" target=\"_blank\" ;=\"\" rel=\"nofollow\">click here</a></span>. </p>\n<p><b><u>More about Crestview Exploration</u></b></p>\n<p>Gold Runner Exploration Inc. is a mineral exploration company focused on advancing a portfolio of gold and silver properties in prolific mining districts in Canada and the United States. Its assets include the Golden Girl Property in British Columbia’s Golden Triangle, several Nevada projects near the Carlin Trend in the Tuscarora Mountains, and a 10% carried interest in the Cimarron project in Nevada’s Walker Lane Trend.</p>\n<p><b>Average Trading Volume:</b> 28,661</p>\n<p><b>Technical Sentiment Signal:</b> Buy</p>\n<p><b>Current Market Cap:</b> C$5.3M</p>\n<p></p>\n<p></p><p>For a thorough assessment of GRUN stock, go to <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/tse:grun\" target=\"_blank\" ;=\"\" rel=\"nofollow\">TipRanks’ Stock Analysis page</a></span>.</p><p></p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_2051377031-1-750x406.jpg",
            "link": "https://www.tipranks.com/news/company-announcements/gold-runner-exploration-grants-2-5-million-stock-options-to-align-team-with-growth-plans",
            "author": "TipRanks Canadian Auto-Generated Newsdesk",
            "pub_date": "2026-02-28 07:16:16",
            "source": "tipranks_announcements",
            "kind": 1,
            "language": "en"
        }
    ]
}